Functional and structural basis of a negative allostery within GABAB hetero-tetramers
Open Access
- 20 March 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
G protein coupled receptors (GPCRs) oligomerization may allow signal integration from different GPCR units. The GABAB receptor, activated by the main inhibitory transmitter, GABA, is an obligatory heterodimer. It is the target of two therapeutic drugs, baclofen and GHB, and can form stable oligomers. The existence, roles, and possible allosteric interaction of GABAB oligomers remain elusive. Here, we show that GABAB oligomers exist in neurons. Their function can be specifically affected by human disease-associated mutations, demonstrating their essential role for normal brain function. The cryo-EM structure of a hetero-tetramer in the apo state reveals the heterodimers interacting in an asymmetrical way to prevent one unit from being activated. This represents a nice example of a negative allosteric interaction between GPCRs related to human diseases.Keywords
This publication has 81 references indexed in Scilit:
- Structural basis of CXCR4 assembly and regulationCell Reports, 2025
- GABBR1 monoallelic de novo variants linked to neurodevelopmental delay and epilepsyThe American Journal of Human Genetics, 2022
- A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett‐like phenotypeAnnals of Neurology, 2018
- Pharmacogenomics of GPCR Drug TargetsCell, 2018
- UCSF ChimeraX: Meeting modern challenges in visualization and analysisProtein Science, 2017
- How Ligands Illuminate GPCR Molecular PharmacologyCell, 2017
- Allosteric Modulation as a Unifying Mechanism for Receptor Function and RegulationCell, 2016
- An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseasesBiotechnology Advances, 2013
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Estimation of agonist affinity and efficacy by direct, operational model-fittingJournal of Pharmacological Methods, 1990